Abstract:Iron deficiency during early infancy adversely impacts the neurodevelopmental and behavioral outcomes in young children [1]. Preterm infants are particularly vulnerable to develop iron deficiency due to their lower iron reserves at birth, rapid growth, and frequent blood draws [2]. We previously reported that one-third of very preterm infants (<31 weeks' gestational age) develop iron deficiency by 6-months of age, despite prophylactic iron supplementation [3]. Currently, the literature regarding iron status in extremely preterm infants (infants born ≤27 weeks gestational age) receiving postnatal prophylactic iron is limited. Considering the long-term detrimental effects of iron deficiency, this study aimed to establish the prevalence and risk factors for iron deficiency in extremely preterm infants. A retrospective cohort study was conducted using a population-based Provincial Perinatal Follow-Up database encompassing all live extremely preterm infants born in Nova Scotia between 2005 and 2018. The present study is a subsequent sub-set analysis of data previously published works by our research team [3]. Infants with congenital malformations, chromosomal anomalies, or blood disorders were excluded. All eligible infants received prophylactic iron supplementation (2–4 mg/kg/day) starting at 2–4 weeks of chronological age in accordance with the Canadian Pediatric Society guidelines [4]. For formula fed preterm infants, iron present in the formula was taken into account while calculating supplemental iron dosage. Iron supplementation dose was further adjusted to a maximum of 6 mg/kg/day based on serum ferritin levels during hospitalization. Discharge instructions recommended continuing iron prophylaxis until 9–12 corrected age. At 4 or 6 months corrected age, hemoglobin and serum ferritin levels were measured again in all infants. Iron deficiency was defined as serum ferritin levels less than 20 mcg/L at 4 months corrected age or less than 12 mcg/L at 6 months corrected age. A univariate analysis using a series of logistic regression models identified the factors associated with iron deficiency. Factors with a p < 0.20 were incorporated into a multivariable risk model using a backward elimination method and were retained if p < 0.05. All tests were two-sided, and all reported values met appropriate test assumptions (i.e., normally distributed where appropriate). This study was approved by the Research Ethics Board of the IWK Health Center (Approval 1024431).

A survey of iron supplementation, iron status surveillance, and erythropoiesis stimulating agent use in level III NICUs in the United States

Iron supplementation in preterm and low-birth-weight infants: a systematic review of intervention studies

Effects of Daily Iron Supplementation on Motor Development and Brain Connectivity in Preterm Infants: A Diffusion Magnetic Resonance Study

Supplemental Iron and Recombinant Erythropoietin for Anemia in Infants Born Very Preterm: A Survey of Clinical Practice in Europe

Screening umbilical cord blood for congenital Iron deficiency

Prevalence of iron deficiency in extreme preterm infants at 4 or 6 months corrected age despite receiving prophylactic iron supplements

Effect of Daily Iron Supplementation on Infantile Iron Homeostasis in Preterm Infants

Iron Metabolism and Brain Development in Premature Infants

Iron Homeostasis Disruption and Oxidative Stress in Preterm Newborns

The impact of iron supplementation on the preterm neonatal gut microbiome: A pilot study

Contribution of Iron Status at Birth to Infant Iron Status at 9 Months: Data from a Prospective Maternal-Infant Birth Cohort in China

A Systematic Review of Isotopically Measured Iron Absorption in Infants and Children Under 2 Years

Iron Supplementation during Pregnancy and Infancy: Uncertainties and Implications for Research and Policy

Iron and Neurodevelopment in Preterm Infants: A Narrative Review

Reticulocyte hemoglobin content as a function of iron stores at 35-36 weeks post menstrual age in very premature infants

Prevalence of and Risk Factors for Iron Deficiency in Twin and Singleton Newborns

The effect of iron supplementation in preterm infants at different gestational ages

Perinatal Outcomes Following Intravenous Iron for Treatment of Iron Deficiency With and Without Anemia

Iron deficiency in infancy: current insights

Low-Dose Iron Supplementation in Infancy Modestly Increases Infant Iron Status at 9 Mo Without Decreasing Growth or Increasing Illness in a Randomized Clinical Trial in Rural China.

The Effects of Prenatal Iron Supplementation on Offspring Neurodevelopment in Upper Middle- or High-Income Countries: A Systematic Review